Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 13,981.41 865.39 213.75 -166.90 35.82 0.03 14.4430 -0.40 -115.2825 -2,534.7213 -9.88 -11.09 785.3614 - -
Maximum - - - - - - 593,737.00 65,349.00 25,407.00 99,050.00 5,305.00 0.94 1,336.3467 6.70 300.5100 8,534.8500 14.64 835.37 6,156.2100 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -10,177.5800 -144,478.0000 -155.91 -1,263.79 0.0700 - -
TG Therapeutics, Inc. TGTX 25.28 0.03 0.12% 3,815 vs. 3,227 3,913.00 63.00 -10.00 -8.00 -1,525.00 -0.0732 -50.4229 0.00 91.30 -16.87 -6.69 -2.87 275.64 154.00
Madrigal Pharmaceuticals, Inc. MDGL 242.25 9.09 3.90% 287 vs. 281 5,259.00 0.00 -147.00 -149.00 -1,483.00 -7.3800 -8.6674 0.00 0.00 0.00 -17.34 -13.63 926.23 21.00
Exelixis, Inc. EXEL 26.83 0.01 0.04% 2,426 vs. 1,764 7,653.00 425.00 37.00 50.00 -258.00 0.1200 47.8131 0.00 95.00 8.78 1.75 1.33 322.73 285.00
Akero Therapeutics, Inc. AKRO 28.00 1.04 3.86% 462 vs. 646 1,944.00 0.00 -53.00 -35.00 -627.00 -0.9000 -6.6902 0.00 0.00 0.00 -6.30 -5.85 2986.43 69.00
Reata Pharmaceuticals, Inc. RETA 172.36 0.04 0.02% 1,909 vs. 954 6,566.00 22.00 192.00 -70.00 -1,490.00 5.1200 5.4820 0.00 96.28 848.49 221.10 38.40 282.09 38.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for TGTX and its peers to uncover potential buy and sell opportunities.